NOMI HEALTH, INC.
On the record as: lobbying client, PAC, lobbyists' giving (LD-203). Also written “NOMI HEALTH”.
$9,500
from its PAC to 5 senators, 2021 on
$2.2M
on 59 lobbying reports as a client
$12K
its lobbyists report giving 6 senators (LD-203)
Its PAC's giving to senators
NOMI HEALTH, INC. PAC
- Democrats $2,000 (21%)
- Republicans $7,500 (79%)
The senators it gave most, colored by party. ◆ marks a senator on a committee that handles what it lobbies on.
Markwayne Mullin
R-OK
$7,000
John R. Curtis
R-UT
$6,000
◆ Pete Ricketts
R-NE · Budget
$3,000
◆ Chris Van Hollen
D-MD · Appropriations, Budget
$2,000
◆ Ron Wyden
D-OR · Budget, Finance
$2,000
◆ Brian Schatz
D-HI · Appropriations
$1,000
All 6 senators
| Senator | From its PAC | Its lobbyists (LD-203) | Sits on, in its lobbying areas |
|---|---|---|---|
| Markwayne Mullin R OK | $3,500 | $3,500 | |
| John R. Curtis R UT | $2,500 | $3,500 | |
| Pete Ricketts R NE | $1,500 | $1,500 | Budget |
| Chris Van Hollen D MD | $1,000 | $1,000 | Appropriations, Budget |
| Ron Wyden D OR | $1,000 | $1,000 | Budget, Finance |
| Brian Schatz D HI | — | $1,000 | Appropriations |
Its lobbying, by year
What its quarterly reports (LD-2) total each year: the fees it paid its lobbying firms, or its own lobbying spending when it lobbies for itself. Latest version of each report.
What it lobbied on
Issues
42 reports
16 reports
6 reports
2 reports
Bills it named
6 reports
6 reports
6 reports
5 reports
5 reports
5 reports
4 reports
4 reports
3 reports
3 reports
The lobbying firms it hired
$1.1M
$425K
$380K
HITTLE STRATEGIES, LLC
$75K
See the data
| Firm | Reports | Fees reported |
|---|---|---|
| HOLLAND & KNIGHT LLP | 14 | $1.1M |
| HB STRATEGIES | 16 | $425K |
| TODD STRATEGY GROUP | 10 | $380K |
| MEHLMAN CONSULTING, INC. | 5 | $210K |
| HITTLE STRATEGIES, LLC | 2 | $75K |
1 of its lobbyists worked for a senator
See the data
| Lobbyist | Former position, as they list it | Senator | Latest report |
|---|---|---|---|
| ETHAN JORGENSEN-EARP | Intern, Sen. Mark R. Warner (D-VA) | Mark R. Warner | 2026 |